|
1
|
Rabe KF, Hurd S, Anzueto A, Barnes PJ,
Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R,
van Weel C, et al Global Initiative for Chronic Obstructive Lung
Disease: Global strategy for the diagnosis, management, and
prevention of chronic obstructive pulmonary disease: GOLD executive
summary. Am J Respir Crit Care Med. 176:532–555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gibson PG and Simpson JL: The overlap
syndrome of asthma and COPD: What are its features and how
important is it? Thorax. 64:728–735. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Evans AM, Hardie DG, Peers C and Mahmoud
A: Hypoxic pulmonary vasoconstriction: Mechanisms of
oxygen-sensing. Curr Opin Anaesthesiol. 24:13–20. 2011. View Article : Google Scholar :
|
|
4
|
Freund-Michel V, Khoyrattee N, Savineau
JP, Muller B and Guibert C: Mitochondria: Roles in pulmonary
hypertension. Int J Biochem Cell Biol. 55:93–97. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kalogeris T, Baines CP, Krenz M and
Korthuis RJ: Cell biology of ischemia/reperfusion injury. Int Rev
Cell Mol Biol. 298:229–317. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li P, Meng X, Bian H, Burns N, Zhao KS and
Song R: Activation of sirtuin 1/3 improves vascular hyporeactivity
in severe hemorrhagic shock by alleviation of mitochondrial damage.
Oncotarget. 6:36998–37011. 2015.PubMed/NCBI
|
|
7
|
Powell RD, Swet JH, Kennedy KL, Huynh TT,
McKillop IH and Evans SL: Resveratrol attenuates hypoxic injury in
a primary hepatocyte model of hemorrhagic shock and resuscitation.
J Trauma Acute Care Surg. 76:409–417. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jian B, Yang S, Chaudry IH and Raju R:
Resveratrol restores sirtuin 1 (SIRT1) activity and pyruvate
dehydrogenase kinase 1 (PDK1) expression after hemorrhagic injury
in a rat model. Mol Med. 20:10–16. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jian B, Yang S, Chaudry IH and Raju R:
Resveratrol improves cardiac contractility following
trauma-hemorrhage by modulating Sirt1. Mol Med. 18:209–214. 2012.
View Article : Google Scholar :
|
|
10
|
Waypa GB, Osborne SW, Marks JD,
Berkelhamer SK, Kondapalli J and Schumacker PT: Sirtuin 3
deficiency does not augment hypoxia-induced pulmonary hypertension.
Am J Respir Cell Mol Biol. 49:885–891. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Paulin R, Dromparis P, Sutendra G, Gurtu
V, Zervopoulos S, Bowers L, Haromy A, Webster L, Provencher S,
Bonnet S, et al: Sirtuin 3 deficiency is associated with inhibited
mitochondrial function and pulmonary arterial hypertension in
rodents and humans. Cell Metab. 20:827–839. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Menzies KJ and Hood DA: The role of SirT1
in muscle mitochondrial turnover. Mitochondrion. 12:5–13. 2012.
View Article : Google Scholar
|
|
13
|
Kong X, Wang R, Xue Y, Liu X, Zhang H,
Chen Y, Fang F and Chang Y: Sirtuin 3, a new target of PGC-1alpha,
plays an important role in the suppression of ROS and mitochondrial
biogenesis. PLoS One. 5:e117072010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Baines CP, Kaiser RA, Purcell NH, Blair
NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA,
Dorn GW, et al: Loss of cyclophilin D reveals a critical role for
mitochondrial permeability transition in cell death. Nature.
434:658–662. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Marzetti E, Calvani R, Cesari M, Buford
TW, Lorenzi M, Behnke BJ and Leeuwenburgh C: Mitochondrial
dysfunction and sarcopenia of aging: From signaling pathways to
clinical trials. Int J Biochem Cell Biol. 45:2288–2301. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Civitarese AE, Carling S, Heilbronn LK,
Hulver MH, Ukropcova B, Deutsch WA, Smith SR and Ravussin E;
CALERIE Pennington Team: Calorie restriction increases muscle
mitochondrial biogenesis in healthy humans. PLoS Med. 4:e762007.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chaung WW, Wu R, Ji Y, Dong W and Wang P:
Mitochondrial transcription factor A is a proinflammatory mediator
in hemorrhagic shock. Int J Mol Med. 30:199–203. 2012.PubMed/NCBI
|
|
18
|
Liu HB, Meng QH, Huang C, Wang JB and Liu
XW: Nephroprotective effects of polydatin against
ischemia/reperfusion injury: A role for the PI3K/Akt signal
pathway. Oxid Med Cell Longev. 2015:3621582015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li XH, Gong X, Zhang L, Jiang R, Li HZ, Wu
MJ and Wan JY: Protective effects of polydatin on septic lung
injury in mice via upregulation of HO-1. Mediators Inflamm.
2013:3540872013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zeng Z, Yang Y, Dai X, Xu S, Li T, Zhang
Q, Zhao KS and Chen Z: Polydatin ameliorates injury to the small
intestine induced by hemorrhagic shock via SIRT3
activation-mediated mitochondrial protection. Expert Opin Ther
Targets. 20:645–652. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang X, Song R, Chen Y, Zhao M and Zhao
KS: Polydatin - a new mitochondria protector for acute severe
hemorrhagic shock treatment. Expert Opin Investig Drugs.
22:169–179. 2013. View Article : Google Scholar
|
|
22
|
Li P, Wang X, Zhao M, Song R and Zhao KS:
Polydatin protects hepatocytes against mitochondrial injury in
acute severe hemorrhagic shock via SIRT1-SOD2 pathway. Expert Opin
Ther Targets. 19:997–1010. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hafner AV, Dai J, Gomes AP, Xiao CY,
Palmeira CM, Rosenzweig A and Sinclair DA: Regulation of the mPTP
by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses
age-related cardiac hypertrophy. Aging (Albany NY). 2:914–923.
2010. View Article : Google Scholar
|
|
24
|
Becker RH, Sha S, Frick AD and Fountaine
RJ: The effect of smoking cessation and subsequent resumption on
absorption of inhaled insulin. Diabetes Care. 29:277–282. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rajendrasozhan S, Yang SR, Kinnula VL and
Rahman I: SIRT1, an antiinflammatory and antiaging protein, is
decreased in lungs of patients with chronic obstructive pulmonary
disease. Am J Respir Crit Care Med. 177:861–870. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Yao H, Sundar IK, Huang Y, Gerloff J,
Sellix MT, Sime PJ and Rahman I: Disruption of sirtuin 1-mediated
control of circadian molecular clock and inflammation in chronic
obstructive pulmonary disease. Am J Respir Cell Mol Biol.
53:782–792. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsu CP, Zhai P, Yamamoto T, Maejima Y,
Matsushima S, Hariharan N, Shao D, Takagi H, Oka S and Sadoshima J:
Silent information regulator 1 protects the heart from
ischemia/reperfusion. Circulation. 122:2170–2182. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cattelan A, Ceolotto G, Bova S, Albiero M,
Kuppusamy M, De Martin S, Semplicini A, Fadini GP, de Kreutzenberg
SV and Avogaro A: NAD(+)-dependent SIRT1 deactivation has a key
role on ischemia-reperfusion-induced apoptosis. Vascul Pharmacol.
70:35–44. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Uittenbogaard M and Chiaramello A:
Mitochondrial biogenesis: a therapeutic target for
neurodevelopmental disorders and neurodegenerative diseases. Curr
Pharm Des. 20:5574–5593. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Pisano A, Cerbelli B, Perli E, Pelullo M,
Bargelli V, Preziuso C, Mancini M, He L, Bates MG, Lucena JR, et
al: Impaired mitochondrial biogenesis is a common feature to
myocardial hypertrophy and end-stage ischemic heart failure.
Cardiovasc Pathol. 25:103–112. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lee D, Kim KY, Noh YH, Chai S, Lindsey JD,
Ellisman MH, Weinreb RN and Ju WK: Brimonidine blocks glutamate
excitotoxicity-induced oxidative stress and preserves mitochondrial
transcription factor a in ischemic retinal injury. PLoS One.
7:e470982012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yin W, Signore AP, Iwai M, Cao G, Gao Y
and Chen J: Rapidly increased neuronal mitochondrial biogenesis
after hypoxic-ischemic brain injury. Stroke. 39:3057–3063. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Larsson NG, Wang J, Wilhelmsson H, Oldfors
A, Rustin P, Lewandoski M, Barsh GS and Clayton DA: Mitochondrial
transcription factor A is necessary for mtDNA maintenance and
embryogenesis in mice. Nat Genet. 18:231–236. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hokari M, Kuroda S, Kinugawa S, Ide T,
Tsutsui H and Iwasaki Y: Overexpression of mitochondrial
transcription factor A (TFAM) ameliorates delayed neuronal death
due to transient forebrain ischemia in mice. Neuropathology.
30:401–407. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liang H and Ward WF: PGC-1alpha: A key
regulator of energy metabolism. Adv Physiol Educ. 30:145–151. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lehman JJ, Barger PM, Kovacs A, Saffitz
JE, Medeiros DM and Kelly DP: Peroxisome proliferator-activated
receptor gamma coactivator-1 promotes cardiac mitochondrial
biogenesis. J Clin Invest. 106:847–856. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Wu Z, Puigserver P, Andersson U, Zhang C,
Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, et
al: Mechanisms controlling mitochondrial biogenesis and respiration
through the thermogenic coactivator PGC-1. Cell. 98:115–124. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kim SY, Shim MS, Kim KY, Weinreb RN,
Wheeler LA and Ju WK: Inhibition of cyclophilin D by cyclosporin A
promotes retinal ganglion cell survival by preventing mitochondrial
alteration in ischemic injury. Cell Death Dis. 5:e11052014.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Gomes AP, Price L, Ling AJ, Moslehi JJ,
Montgomery MK, Rajman L, White JP, Teodoro JS, Wrann CD, Hubbard
BP, et al: Declining NAD(+) induces a pseudohypoxic state
disrupting nuclear-mitochondrial communication during aging. Cell.
155:1624–1638. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Joo HY, Yun M, Jeong J, Park ER, Shin HJ,
Woo SR, Jung JK, Kim YM, Park JJ, Kim J, et al: SIRT1 deacetylates
and stabilizes hypoxia-inducible factor-1α (HIF-1α) via direct
interactions during hypoxia. Biochem Biophys Res Commun.
462:294–300. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lagouge M, Argmann C, Gerhart-Hines Z,
Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P,
Elliott P, et al: Resveratrol improves mitochondrial function and
protects against metabolic disease by activating SIRT1 and
PGC-1alpha. Cell. 127:1109–1122. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Kwon SM, Park HG, Jun JK and Lee WL:
Exercise, but not quercetin, ameliorates inflammation,
mitochondrial biogenesis, and lipid metabolism in skeletal muscle
after strenuous exercise by high-fat diet mice. J Exerc Nutrition
Biochem. 18:51–60. 2014. View Article : Google Scholar
|
|
43
|
Higashida K, Kim SH, Jung SR, Asaka M,
Holloszy JO and Han DH: Effects of resveratrol and SIRT1 on PGC-1α
activity and mitochondrial biogenesis: A reevaluation. PLoS Biol.
11:e10016032013. View Article : Google Scholar
|
